KAYLA YARBROUGH: Open Payments
NPI 1407597388 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,291 in 172 payments from 19 companies in 2025. Trend: 2023 $1,768 · 2024 $2,639 · 2025 $3,291
Food & beverage: $3,108Education: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $737 |
| Janssen Biotech, Inc. | 15 | $414 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $343 |
| Regeneron Healthcare Solutions, Inc. | 10 | $267 |
| Madrigal Pharmaceuticals | 12 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $189 |
| GENZYME CORPORATION | 7 | $177 |
| Ardelyx, Inc. | 9 | $164 |
| Lilly USA, LLC | 8 | $144 |
| QOL Medical, LLC | 4 | $125 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, XIFAXAN, REZDIFFRA, RINVOQ, IBSRELA, OMVOH.
Industry payments across GA — which companies pay providers there.
